Response by Sharp to: “Ozempic Face” in Plastic Surgery: A Systematic Review of the Literature on GLP-1 Receptor Agonist Mediated Weight Loss and Analysis of Public Perceptions” by Daneshgaran et al
Gemma Sharp · 2026
Read Response by Sharp to: “Ozempic Face” in Plastic Surgery: A Systematic Review of the Literature on GLP-1 Receptor Agonist Mediated Weight Loss and Analysis of Public Perceptions” by Daneshgaran et al by Gemma Sharp (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13225259.txt.
Description
Gemma Sharp replied in 2026 to a review on the phrase Ozempic face in plastic surgery. The review, by Daneshgaran and co-authors, gathered early literature on facial change after weight loss driven by GLP-1 drugs. Sharp accepts its surgical points but questions the framing of a distinct clinical syndrome. The studies reviewed are mostly low-level evidence, with no controlled data showing a face pattern unique to these drugs.
Volume loss and skin laxity follow any rapid weight loss, drug-led or not. Search trend data in the review may track how catchy the term is, not how common a condition is. Sharp urges care before a media label hardens into a diagnosis.
Catalog record
| CREATOR | Gemma Sharp |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 3 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |